Can clinical data help to screen patients with lymphoma for MR imaging of bone marrow?

Annals of Oncology : Official Journal of the European Society for Medical Oncology
A A TardivonD Vanel

Abstract

Previous studies have suggested combining magnetic resonance (MR) imaging and biopsy in patients with lymphoma but association between MR results and clinical symptoms have never been investigated. The purpose of this retrospective study was to better delineate patients profiles requiring bone marrow (BM) imaging in lymphoma. 50 MR studies and blind biopsies (BB) were reviewed in 40 patients with lymphoma. MR results were compared to clinical, laboratory-based and BM follow-up data to determine potential associations between MR results and these parameters. 46% of MR studies were abnormal with a normal BB; 2% were normal with an abnormal BB. Abnormal MR results were significantly associated with subsequent bone marrow involvement (p < 0.01). Abnormal MR studies were significantly associated with constitutional symptoms, bone pains (p < 0.05) and an elevated alkaline phosphatase level (p < 0.01). MR imaging excluded malignancy in three patients and caused therapy to be modified in three. Abnormal clinical and laboratory-based data should be used to screen patients with normal BB for MR imaging, especially in patients with Hodgkin's disease and high grade non-Hodgkin's lymphoma.

Citations

Mar 8, 2008·British Journal of Haematology·Thomas C KweeRutger A J Nievelstein
Mar 1, 1997·Leukemia & Lymphoma·A A TardivonJ Bosq
Mar 28, 2002·Cancer Biotherapy & Radiopharmaceuticals·Gerald L DeNardoSally J DeNardo
Jun 14, 2003·Cancer Biotherapy & Radiopharmaceuticals·Gerald DeNardoSally DeNardo
Dec 21, 2007·European Journal of Radiology·K L Verstraete, W C J Huysse

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Related Papers

Journal of Magnetic Resonance Imaging : JMRI
Bensheng QiuXiaoming Yang
RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin
L W PollU Mödder
Journal of Medical Imaging and Radiation Oncology
Jennifer BrackenMichael Ditchfield
Indian Journal of Pathology & Microbiology
Suneet KumarUrmila N Khadilkar
Journal of Computer Assisted Tomography
Tomoko ManabeKazuro Sugimura
© 2021 Meta ULC. All rights reserved